Skin abnormalities as an early predictor of neurologic outcome in Gaucher disease

被引：18

作者：

Holleran, WM

Ziegler, SG

Goker-Alpan, O

Eblan, MJ

Elias, PM

Schiffmann, R

Sidransky, E

机构：

[1] NHGRI, Sect Mol Neurogenet, Med Genet Branch, Bethesda, MD 20892 USA

[2] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA

[3] Univ Calif San Francisco, Sch Med, Dept Pharmaceut Chem, San Francisco, CA 94143 USA

[4] Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, San Francisco, CA 94143 USA

[5] NINDS, Dev & Metab Neurol Branch, NIH, Bethesda, MD 20892 USA

来源：

CLINICAL GENETICS | 2006年 / 69卷 / 04期

关键词：

D O I：

10.1111/j.1399-0004.2006.00589.x

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

引用

页码：355 / 357

页数：3

共 14 条

[1] The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher's disease [J].

Altarescu, G ;

Hill, S ;

Wiggs, E ;

Jeffries, N ;

Kreps, C ;

Parker , CC ;

Brady, RO ;

Barton, NW ;

Schiffmann, R ;

Bannarjee, TK ;

Crutchfield, K ;

Frei, K ;

McKee, MA ;

Moore, DF ;

Tournay, A .

JOURNAL OF PEDIATRICS, 2001, 138 (04) :539-547

[2]

Beutler E., 2001, METABOLIC MOL BASES, V3, P3635

[3] Perinatal lethal Gaucher disease: A distinct phenotype along the neuronopathic continuum [J].

Eblan, MJ ;

Goker-Alpan, O ;

Sidransky, E .

FETAL AND PEDIATRIC PATHOLOGY, 2005, 24 (4-5) :205-222

[4]

Frederickson DS, 1972, METABOLIC BASIS INHE, P730

[5] CONSEQUENCES OF BETA-GLUCOCEREBROSIDASE DEFICIENCY IN EPIDERMIS - ULTRASTRUCTURE AND PERMEABILITY BARRIER ALTERATIONS IN GAUCHER DISEASE [J].

HOLLERAN, WM ;

GINNS, EI ;

MENON, GK ;

GRUNDMANN, JU ;

FARTASCH, M ;

MCKINNEY, CE ;

ELIAS, PM ;

SIDRANSKY, E .

JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (04) :1756-1764

[6]

Knudson AG., 1962, GENETICS SPHINGOLIPI

[7] Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease [J].

Koprivica, V ;

Stone, DL ;

Park, JK ;

Callahan, M ;

Frisch, A ;

Cohen, IJ ;

Tayebi, N ;

Sidransky, E .

AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 66 (06) :1777-1786

[8]

Prows CA, 1997, AM J MED GENET, V71, P16, DOI 10.1002/(SICI)1096-8628(19970711)71:1<16::AID-AJMG3>3.3.CO

[9]

2-U

[10] Type 2 Gaucher disease with hydrops fetalis in an Ashkenazi Jewish family resulting from a novel recombinant allele and a rare splice junction mutation in the glucocerebrosidase locus [J].

Reissner, K ;

Tayebi, N ;

Stubblefield, BK ;

Koprivica, V ;

Blitzer, M ;

Holleran, W ;

Cowan, T ;

Almashanu, S ;

Maddalena, A ;

Karson, EM ;

Sidransky, E .

MOLECULAR GENETICS AND METABOLISM, 1998, 63 (04) :281-288

← 1 2 →